Teams of researchers from MIT and Harvard have developed an efficient process that can convert carbon dioxide into formate – a material that can be used like hydrogen or methanol to power a fuel cell Read More
The US Department of Energy (DOE) has funded the development of a microgrid orchestrator designed to establish a network of microgrids that can be managed as a single cluster – essentially creating a grid of Read More
Researchers at the University of Cambridge have developed a floating, solar-powered device that can turn contaminated water or seawater into clean hydrogen fuel and purified water. The technology has potential for use in areas which Read More
Due: February 29, 2024 The Department of Energy’s (DOE) Office of Clean Energy Demonstrations (OCED) is issuing this Funding Opportunity Announcement (FOA) to support a portfolio of projects that demonstrate and validate reliable operations and Read More
DUE: February 29, 2024 The BER ESS program goal is to advance an integrated, robust, and scale-aware predictive understanding of terrestrial systems and their interdependent microbial, biogeochemical, ecological, hydrological, and physical processes.
DUE: February 28, 2024 This Concept supports clinical studies applications to study psychedelic treatment administration paradigms, assess the role of psychotherapy in its administration, and describe and assess the range of clinical outcomes, including downstream Read More
DUE: February 26, 2024 The overarching purpose of the U.S. Integrated Ocean Observing System (IOOS®) is to address regional and national needs for ocean information, to gather reliable data on key coastal, ocean, and Great Read More
DUE: February 22, 2024 The National Sea Grant College Program was enacted to support leveraged federal and state partnerships that harness the intellectual capacity of the nation’s universities and research institutions to solve problems and Read More
DUE: February 22, 2024 The purpose of this NOFO is to provide support for applications for IND-enabling studies for the development of a novel in vivo genome editing therapeutic platform (genome editor plus delivery system) Read More
DUE: February 20, 2024 This RFA will solicit applications for a pivotal phase 3 clinical trial to determine the efficacy of FDA approved monoclonal antibody therapy compared to placebo in diverse “mixed dementia” populations with Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.